Breaking News Instant updates and real-time market news.

BAYRY

Bayer

$34.24

-0.37 (-1.07%)

, JNJ

Johnson & Johnson

$133.19

0.3 (0.23%)

06:21
10/06/17
10/06
06:21
10/06/17
06:21

Bayer keeping forecast for peak Xarelto annual sales, Reuters reports

Despite new study results, Bayer is keeping its forecast for peak Xarelto annual sales, Reuters reports. Reference Link

BAYRY

Bayer

$34.24

-0.37 (-1.07%)

JNJ

Johnson & Johnson

$133.19

0.3 (0.23%)

  • 08

    Oct

  • 17

    Oct

  • 23

    Oct

  • 06

    Nov

  • 08

    Nov

  • 16

    Nov

BAYRY Bayer
$34.24

-0.37 (-1.07%)

08/18/17
UBSW
08/18/17
DOWNGRADE
Target $128
UBSW
Neutral
Monsanto downgraded to Neutral from Buy at UBS
UBS analyst John Roberts downgraded Monsanto (MON) to Neutral saying the shares are now less than 10% away from the accepted Bayer (BAYRY) offer of $128. The analyst calculates that the market is currently pricing in a 70% chance of the deal going through. His view that the deal could be approved remains unchanged. Approvals of peer deals suggest antitrust approval likely for Monsanto, Roberts tells investors in a research note. The analyst keeps a $128 price target for Monsanto shares.
09/05/17
BERN
09/05/17
NO CHANGE
BERN
Bernstein still sees 'very high' probability of Bayer, Monsanto deal approval
Bernstein analyst Jeremy Redenius notes that the European Commission has opened an in-depth review of the Bayer (BAYRY)/Monsanto (MON) deal due to concerns of reduced competition in pesticides, seeds, and traits. The analyst believes this is not surprising, as the in-depth review is the norm for deals of this size. Comparing the EC's initial concerns with those of the Dow/DuPont (DWDP) deal, he still sees a "very high" probability of deal approval.
09/18/17
JEFF
09/18/17
NO CHANGE
JEFF
AbbVie remains top global Pharma pick at Jefferies
Jefferies analyst Jeffrey Holford says AbbVie (ABBV) remains his top global pick in Pharmaceuticals, followed by Bayer (BAYRY). In the U.S., the analyst lists Zoetis (ZTS), Bristol-Myers Squibb (BMY) and Eli Lilly (LLY) as his top picks behind AbbVie. Merck (MRK) and Novo Nordisk (NVO) are the analyst's least preferred stocks. Holford cut his price target for Underperform-rated Merck to $52 from $55 and raised his price target for Buy-rated Zoetis to $77 from $74.
10/03/17
RHCO
10/03/17
NO CHANGE
RHCO
TG Therapeutics has positive read through from Bayer approval, says SunTrust
SunTrust analyst Yatin Suneja believes that the FDA's decision to grant accelerated approval to Bayer's (BAYRY) Aliqopa, a PI3K-delta inhibitor, as a treatment for Relapsed/Refractory Follicular Lymphoma, bodes well for TG Therapeutics' (TGTX) own PI3K-delta inhibitor, TGR-120. The analyst says that the lack of a black box warning on Bayer's Aliqopa shows that not all PI3K-delta inhibitors have the safety issues that have been attributed to them in the past. Suneja says that "Aliqopa's approval reflects positively on TGR-1202, which offers best-in-class safety , and provides clarity on TGR-1202's regulatory pathway in" lymphoma The analyst says that investors are "overlooking" its potential in " lymphoma, and keeps a Buy rating on the shares.
JNJ Johnson & Johnson
$133.19

0.3 (0.23%)

09/25/17
09/25/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Johnson & Johnson (JNJ) initiated with a Neutral at Citi. 2. CoreSite Realty (COR) initiated with a Neutral at JPMorgan. 3. Hi-Crush Partners (HCLP) initiated with an Overweight at Piper Jaffray. 4. Zillow (Z, ZG) initiated with a Neutral at Macquarie. 5. Big Lots (BIG) initiated with an Overweight at Morgan Stanley. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
10/03/17
SBSH
10/03/17
NO CHANGE
SBSH
Citi's general surgery survey 'very positive' for Intuitive Surgical
Citi analyst Amit Hazan says his firm's general surgery survey is "very positive" for Intuitive Surgical (ISRG), and "much less so" for Medtronic (MDT) and Johnson & Johnson (JNJ). Robotic procedures are expected to be up about 30% this year and next, with ventral hernia leading, Hazan tells investors in a research note partially titled "It's a Good Time to be a Robot." He believes robotic is really starting to hurt laparoscopy and that Medtronic and J&J will likely be forced to talk about the headwind publicly.
10/05/17
PIPR
10/05/17
NO CHANGE
PIPR
J&J exit from insulin pumps a 'clear win' for Medtronic, says Piper Jaffray
After Animas, one of Johnson & Johnson's (JNJ) companies, announced that it intends to discontinue the manufacturing and sale of insulin pumps and selected Medtronic (MDT) as its transition partner, Piper Jaffray analyst Matt O'Brien called the news a "clear win" for Medtronic. For DexCom (DXCM), which has partnered with Animas, this decision is likely a modest negative, while Insulet (PODD) and Tandem (TNDM) may be able to capture some share from Animas pump patients who look for other therapeutic options, added O'Brien.
10/05/17
COWN
10/05/17
NO CHANGE
COWN
J&J exit 'great opportunity' for Insulet and Tandem, says Cowen
Cowen analyst Doug Schenkel says close to 10% of the U.S. insulin pump market is up for grabs over the next two years after Johnson & Johnson's (JNJ) Animas announced it is exiting the pump business. Medtronic (MDT) is likely to get the majority of patients initially, but the news is a "great opportunity" for Insulet (PODD) and Tandem Diabetes Care (TNDM), Schenkel tells investors in a research note. The analyst sees risk for Dexcom (DXCM), but believes the vast majority of its users will remain, regardless of pump choice.

TODAY'S FREE FLY STORIES

MTN

Vail Resorts

$280.81

-4.21 (-1.48%)

07:11
06/20/18
06/20
07:11
06/20/18
07:11
Initiation
Vail Resorts initiated  »

Vail Resorts initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

POOL

Pool Corp.

$154.54

0.52 (0.34%)

07:10
06/20/18
06/20
07:10
06/20/18
07:10
Initiation
Pool Corp. initiated  »

Pool Corp. initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PLNT

Planet Fitness

$45.11

-0.5 (-1.10%)

07:09
06/20/18
06/20
07:09
06/20/18
07:09
Initiation
Planet Fitness initiated  »

Planet Fitness initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NLS

Nautilus

$16.40

-0.1 (-0.61%)

07:09
06/20/18
06/20
07:09
06/20/18
07:09
Initiation
Nautilus initiated  »

Nautilus initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SRPT

Sarepta

$143.92

38.44 (36.44%)

07:09
06/20/18
06/20
07:09
06/20/18
07:09
Recommendations
Sarepta analyst commentary  »

Sarepta price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

GLOB

Globant

$56.99

-0.01 (-0.02%)

07:09
06/20/18
06/20
07:09
06/20/18
07:09
Syndicate
Globant announces commencement of 5.8M share secondary offering »

WPP plc (WPP) and Globant…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

FOXF

Fox Factory

$44.10

0.2 (0.46%)

07:09
06/20/18
06/20
07:09
06/20/18
07:09
Initiation
Fox Factory initiated  »

Fox Factory initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HSGX

Histogenics

$2.74

-0.13 (-4.53%)

07:06
06/20/18
06/20
07:06
06/20/18
07:06
Recommendations
Histogenics analyst commentary  »

Histogenics Phase 3 study…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BDRBF

Bombardier

$0.00

(0.00%)

, DAL

Delta Air Lines

$53.78

-1.025 (-1.87%)

07:06
06/20/18
06/20
07:06
06/20/18
07:06
Hot Stocks
Delta Air Lines orders 20 Bombardier CRJ900 valued at approx. $961M »

Bombardier Commercial…

BDRBF

Bombardier

$0.00

(0.00%)

DAL

Delta Air Lines

$53.78

-1.025 (-1.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 29

    Jun

APEN

Apollo Endosurgery

$5.60

-0.3 (-5.08%)

07:06
06/20/18
06/20
07:06
06/20/18
07:06
Syndicate
Apollo Endosurgery 3.747M share Spot Secondary priced at $5.50 »

Craig-Hallum acted as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AIG

AIG

$55.50

-0.065 (-0.12%)

07:05
06/20/18
06/20
07:05
06/20/18
07:05
Hot Stocks
AIG acquires Ellipse from Munich Re »

AIG and Munich Re…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DUK

Duke Energy

$75.67

1.28 (1.72%)

07:05
06/20/18
06/20
07:05
06/20/18
07:05
Upgrade
Duke Energy rating change  »

Duke Energy upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WGO

Winnebago

$40.40

-0.35 (-0.86%)

07:04
06/20/18
06/20
07:04
06/20/18
07:04
Earnings
Winnebago reports Q3 EPS $1.02, consensus 91c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

07:04
06/20/18
06/20
07:04
06/20/18
07:04
General news
MBA Mortgage Applications Composite Index data reported »

Week of 6/15 MBA Mortgage…

SPX

S&P 500

$0.00

(0.00%)

07:04
06/20/18
06/20
07:04
06/20/18
07:04
Technical Analysis
S&P 500: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRX

Amneal Pharmaceuticals

$18.83

-0.69 (-3.53%)

07:03
06/20/18
06/20
07:03
06/20/18
07:03
Hot Stocks
Amneal announces patent litigation settlement agreement with Actavis »

Amneal Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PGLC

Pershing Gold

$1.86

-0.04 (-2.11%)

07:03
06/20/18
06/20
07:03
06/20/18
07:03
Hot Stocks
Pershing Gold files Plan of Operations for Relief Canyon Mine expansion »

Pershing Gold submitted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GDX

Market Vector Gold Miners

$22.05

-0.24 (-1.08%)

07:02
06/20/18
06/20
07:02
06/20/18
07:02
Technical Analysis
Market Vector Gold Miners: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$197.46

-0.84 (-0.42%)

, SSNLF

Samsung

$0.00

(0.00%)

07:02
06/20/18
06/20
07:02
06/20/18
07:02
Hot Stocks
IDC: Worldwide shipments of AR, VR headsets down 30.5% in Q1 to 1.2M units »

Worldwide shipments of…

FB

Facebook

$197.46

-0.84 (-0.42%)

SSNLF

Samsung

$0.00

(0.00%)

GOOG

Alphabet

$1,167.86

-5.77 (-0.49%)

GOOGL

Alphabet Class A

$1,178.29

-5.69 (-0.48%)

AAPL

Apple

$185.69

-3.07 (-1.63%)

MSFT

Microsoft

$100.89

0.01 (0.01%)

HPQ

HP Inc.

$23.53

-0.125 (-0.53%)

LNVGY

Lenovo

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

  • 28

    Oct

GLD

SPDR Gold Trust

$120.84

-0.28 (-0.23%)

07:02
06/20/18
06/20
07:02
06/20/18
07:02
Technical Analysis
SPDR Gold Trust: Pivot points, pivot low broken »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CUB

Cubic

$67.00

0.25 (0.37%)

07:02
06/20/18
06/20
07:02
06/20/18
07:02
Hot Stocks
Cubic's CTS unit awarded contract valued at approximately $276M »

Cubic announced its Cubic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JKS

JinkoSolar

$12.14

-0.73 (-5.67%)

07:01
06/20/18
06/20
07:01
06/20/18
07:01
Hot Stocks
JinkoSolar supplies 275.4 MWdc solar moduals to Green Light Contractors »

JinkoSolar Holding…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

NUGT

Direxion Gold Miners Bull

$23.99

-0.73 (-2.95%)

07:01
06/20/18
06/20
07:01
06/20/18
07:01
Technical Analysis
Direxion Gold Miners Bull: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNUG

Direxion Daily Jr Gld Mnrs Bull 3X Shrs

$13.49

-0.31 (-2.25%)

07:00
06/20/18
06/20
07:00
06/20/18
07:00
Technical Analysis
Direxion Daily Jr Gld Mnrs Bull 3X Shrs: Pivot points, pivot low broken »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DUST

Direxion Daily Gold Miners Bear 3X ETF

$24.99

0.69 (2.84%)

07:00
06/20/18
06/20
07:00
06/20/18
07:00
Technical Analysis
Direxion Daily Gold Miners Bear 3X ETF: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.